ijms-logo

Journal Browser

Journal Browser

Heart Failure: From Molecular Mechanisms to Clinically Translational Innovations

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 December 2025 | Viewed by 10

Special Issue Editor


E-Mail Website
Guest Editor
Cellular, Molecular and Clinical Pathological Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90134 Palermo, Italy
Interests: genetic and pathology of aortopathy and cerebrovascular diseases; inflammatpry diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Heart failure (HF) is a cardiac syndrome characterized by the presence of nonspecific signs and symptoms, such as weakness and dyspnea. These signs, such as left ventricular edema, overlap with other pathological conditions, such as chronic kidney disease and liver failure. However, in HF, symptoms reflect the deterioration of left ventricular function, which is notoriously associated with high rates of morbidity and mortality, with a significant economic impact on healthcare services. HF is, in fact, now considered a major public health problem. Its management is complex, and using traditional blood biomarkers is inappropriate. Panels of molecules and metabolic pathways, reflecting its complex pathophysiology, could represent optimal biochemical biomarkers, as well as targets. These, when integrated with imaging biomarkers, could facilitate the diagnosis of HF, as well as prognosis, outcomes, and therapies. The available literature provides increasing evidence on emerging biomarkers, as well as innovative treatments, such as targeted therapies, developed through applying artificial intelligence and multi-omics technologies. These efforts aimed to facilitate diagnosis, predict prognosis and outcomes, and suggest more innovative and personalized therapies. This Special Issue is dedicated to furthering this line of research, and contributions should include original articles, reviews, short communications, and letters.

Dr. Carmela Rita Balistreri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart failure
  • pathophysiology
  • cellular and molecular mechanisms
  • traditional biomarkers: limits and benefits
  • emerging molecular biomarkers
  • innovative therapies, i.e., personalized therapies, targeted therapies, etc.
  • the application of artificial intelligence
  • multi-omics technologies
  • imaging innovative biomarkers
  • clinical translation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop